Daniel L. Weiner Sells 750 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock

Simulations Plus, Inc. (NASDAQ:SLP) Director Daniel L. Weiner sold 750 shares of Simulations Plus stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $49.32, for a total value of $36,990.00. Following the completion of the transaction, the director now owns 7,009 shares in the company, valued at approximately $345,683.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Simulations Plus Stock Performance

Simulations Plus stock opened at $46.86 on Wednesday. The stock’s 50 day simple moving average is $47.81 and its two-hundred day simple moving average is $44.18. The stock has a market cap of $936.73 million, a price-to-earnings ratio of 88.42 and a beta of 0.72. Simulations Plus, Inc. has a fifty-two week low of $32.69 and a fifty-two week high of $52.69.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. The business had revenue of $18.31 million for the quarter, compared to analysts’ expectations of $17.31 million. During the same period in the previous year, the firm posted $0.20 EPS. The business’s revenue was up 16.2% on a year-over-year basis. On average, analysts predict that Simulations Plus, Inc. will post 0.55 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on SLP shares. Oppenheimer boosted their price target on Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a report on Thursday, June 13th. William Blair started coverage on Simulations Plus in a report on Friday, June 28th. They set an “outperform” rating on the stock. Finally, Craig Hallum boosted their price target on Simulations Plus from $51.00 to $56.00 and gave the company a “buy” rating in a report on Thursday, June 13th.

Institutional Trading of Simulations Plus

Hedge funds have recently made changes to their positions in the stock. EntryPoint Capital LLC bought a new stake in shares of Simulations Plus in the 1st quarter worth approximately $57,000. Allspring Global Investments Holdings LLC bought a new position in Simulations Plus in the 1st quarter valued at approximately $70,000. Connecticut Wealth Management LLC purchased a new stake in Simulations Plus during the 1st quarter valued at $204,000. Canton Hathaway LLC raised its stake in Simulations Plus by 25.0% during the 4th quarter. Canton Hathaway LLC now owns 5,000 shares of the technology company’s stock valued at $224,000 after buying an additional 1,000 shares during the last quarter. Finally, Janney Montgomery Scott LLC purchased a new stake in Simulations Plus during the 1st quarter valued at $208,000. 78.08% of the stock is owned by institutional investors.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.